Insider selling
Traded Nov 6 · filed 8 days laterNot reported under a pre-arranged trading plan
A major shareholder of Neuronetics sold $599K of Neuronetics shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 30, 2026 · Filed Nov 2, 2026
A major shareholder of Neuronetics paid $41K out of pocket for Neuronetics shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$40,860
Shares × reported transaction price
$25K–$100K
+0.2%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 2 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 14 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
80 days after results of Aug 11, 2026, 5 days before results of Nov 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $2.25 on Oct 30, 2026, 91% above its 52-week low and 32% below its high, after a 22% drop over the previous 30 trading days
52-week range $1.18 (May 18, 2026) to $3.30 (Aug 14, 2026), 50% of the way up, from 251 adjusted closes. 30 trading days earlier: $2.90 on Sep 18, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded 5 days before STIM reported its results (Nov 4, 2026)
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −11.1% | −0.6% | −10.5% |
Past results only. Not a forecast.
Insider selling
Traded Nov 6 · filed 8 days laterNot reported under a pre-arranged trading plan
A major shareholder of Neuronetics sold $599K of Neuronetics shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 9 · filed 5 days laterNot reported under a pre-arranged trading plan
A major shareholder of Neuronetics sold $214K of Neuronetics shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 11 · filed 3 days laterNot reported under a pre-arranged trading plan
A major shareholder of Neuronetics sold $140K of Neuronetics shares. The filing does not indicate a pre-arranged trading plan.
Chernett Jorey, 10% owner's past purchases, 90 days after disclosure: 21 buys, median +52.0 pts vs S&P 500, beat it 16 of 21 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.